Nebraska § 71-9602 Terms, defined

Nebraska Statutes

§ 71-9602 — Terms, defined

Nebraska § 71-9602

Ch. 71Public Health and Welfare

This text of Nebraska § 71-9602 (Terms, defined) is published on Counsel Stack Legal Research, covering Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Neb. Rev. Stat. § 71-9602 (2026).

Text

For purposes of the Investigational Drug Use Act:

(1)Advanced illness means any progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of federally approved and available treatments, and that, without life-sustaining procedures, would likely result in death within six months;

(2)Eligible patient means a person who meets the requirements of section 71-9603 ;

(3)Health care provider has the same meaning as in section 71-7907 ;

(4)Investigational drug, biological product, or device means any drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States

Free access — add to your briefcase to read the full text and ask questions with AI

For purposes of the Investigational Drug Use Act:
(1) Advanced illness means any progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of federally approved and available treatments, and that, without life-sustaining procedures, would likely result in death within six months;
(2) Eligible patient means a person who meets the requirements of section 71-9603 ;
(3) Health care provider has the same meaning as in section 71-7907 ;
(4) Investigational drug, biological product, or device means any drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in a clinical trial approved by the United States Food and Drug Administration;
(5) Physician means any person who is licensed to practice medicine and surgery pursuant to the Medicine and Surgery Practice Act; and
(6) Written, informed consent means a writing which conforms to section 71-9604 .